|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
JPRN |
|
Last refreshed on:
|
17 October 2023 |
|
Main ID: |
JPRN-UMIN000009547 |
|
Date of registration:
|
01/01/2013 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Prospectivestudy on the treatment effect of pancrelipase on chronic pancreatitis patient's alubumin concentration
|
|
Scientific title:
|
Prospectivestudy on the treatment effect of pancrelipase on chronic pancreatitis patient's alubumin concentration - Examination of effect to albumin with pancrelipase in chronic pancreatitis |
|
Date of first enrolment:
|
2012/08/01 |
|
Target sample size:
|
83 |
|
Recruitment status: |
Recruiting |
|
URL:
|
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011185 |
|
Study type:
|
Interventional |
|
Study design:
|
Single arm Non-randomized
|
|
Phase:
|
Not applicable
|
|
|
Countries of recruitment
|
|
Japan
| | | | | | | |
|
Contacts
|
|
Name:
|
Kazuo Inui |
|
Address:
|
3-6-10,Otobashi,Nakagawa-ku,Nagoya
Japan |
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Department of Internal Medicine Second Teaching Hospital Fujita Health University School of Medicine Gastroenterology |
|
|
Name:
|
Tomoji Yamamoto |
|
Address:
|
3-6-10,Otobashi,Nakagawa-ku,Nagoya
Japan |
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Department of Internal Medicine Second Teaching Hospital Fujita Health University School of Medicine Gastroenterology |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria:
Exclusion criteria: 1)Alegyin procion protein or digestive enzym 2)Case with possibility of pregnancy,during nursing 3)Participates in other examinations. 4)Sever infection 5)In addition, the case judged to be inappropriate for the examination to carry out this study safely
Age minimum:
20years-old
Age maximum:
Not applicable
Gender:
Male and Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Chronic pancreatitis
|
|
Intervention(s)
|
|
600mg of Pancrelipase (granules or capsels) to be taken three times a day (1800mg /day) after meals for 4 weeks.
|
|
Primary Outcome(s)
|
|
Improvement of albumin
|
|
Secondary Outcome(s)
|
|
1)Change of amylase and lipase 2)Improvement of nutrition 3)Improvement of VAS score 4)Improvement of dyspepsia 5)Improvement of stool consistency and count
|
|
Source(s) of Monetary Support
|
|
None
|
|
Ethics review
|
Status: YES
Approval date:
Contact:
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|